Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
How do we make progress in phenotyping patients with lower urinary tract such as overactive bladder and underactive detrusor, including using urine markers and microbiome data, to personalize therapy? ICI-RS 2023-Part 2.
Finazzi Agrò E, Rosato E, Wagg A, Sinha S, Fede Spicchiale C, Serati M, Mancini V, de Rijk M, Tarcan T, Wein A, Abrams P, Bou Kheir G. Finazzi Agrò E, et al. Among authors: mancini v. Neurourol Urodyn. 2024 Jan 4. doi: 10.1002/nau.25379. Online ahead of print. Neurourol Urodyn. 2024. PMID: 38178629
Impact of Overactive Bladder-Wet Syndrome on Female Sexual Function: A Systematic Review and Meta-Analysis.
Balzarro M, Rubilotta E, Mancini V, Trabacchin N, Oppezzi L, Li Marzi V, Fusco F, Serati M. Balzarro M, et al. Among authors: mancini v. Sex Med Rev. 2019 Oct;7(4):565-574. doi: 10.1016/j.sxmr.2019.05.002. Epub 2019 Jul 17. Sex Med Rev. 2019. PMID: 31326358
CONCLUSION: OAB-wet represents a risk for sexual dysfunction; however, data available show low-quality evidence of the impact of OAB-wet on sexual dysfunction. Balzarro M, Rubilotta E, Mancini V, et al. Impact of Overactive Bladder-Wet Syndrome on Female Sexual Func …
CONCLUSION: OAB-wet represents a risk for sexual dysfunction; however, data available show low-quality evidence of the impact of OAB-wet on …
How can we better manage drug-resistant OAB/DO? ICI-RS 2018.
Chermansky C, Schurch B, Rahnama'i MS, Averbeck MA, Malde S, Mancini V, Valentini F, Sahai A. Chermansky C, et al. Among authors: mancini v. Neurourol Urodyn. 2019 Dec;38 Suppl 5:S46-S55. doi: 10.1002/nau.24055. Neurourol Urodyn. 2019. PMID: 31821628 Review.
How do we make progress in phenotyping patients with LUT such as OAB and underactive detrusor, including using urine markers and microbiome data, in order to personalize therapy? ICI-RS 2023: Part 1.
Finazzi Agrò E, Rosato E, Wagg A, Sinha S, Fede Spicchiale C, Serati M, Mancini V, de Rijk M, Tarcan T, Wein A, Abrams P, Bou Kheir G. Finazzi Agrò E, et al. Among authors: mancini v. Neurourol Urodyn. 2024 Jan 4. doi: 10.1002/nau.25377. Online ahead of print. Neurourol Urodyn. 2024. PMID: 38178627
Antibiotic prophylaxis in invasive urodynamics, a Delphi consensus of the Italian Society of Urodynamics (SIUD).
Rubilotta E, Chiarulli EF, Ammirati E, Bevacqua MC, Manodoro S, Chierchia S, Fragalà E, Masiello G, Li Marzi V, Giammò A, Musco S, Savoca F, Balzarro M, De Nunzio C, De Rienzo G, Fusco F, Lamberti G, Soligo M, De Palma L, Fasano M, Carretta A, Tumietto F, Finazzi-Agrò E, Russo E, Antonelli A, Gubbiotti M, Sampogna G, Spinelli M, Carone R, Martino L, Mancini V; Italian Society of Urodynamics (SIUD). Rubilotta E, et al. Among authors: mancini v. Neurourol Urodyn. 2024 Apr 8. doi: 10.1002/nau.25463. Online ahead of print. Neurourol Urodyn. 2024. PMID: 38587242
Wound dehiscence prevalence and relationship with prosthetic material extrusion in women underwent anterior colpotomy.
Balzarro M, Rubilotta E, Mancini V, Serati M, Gubbiotti M, Braga A, Saleh O, Torrazzina M, Malanowska E, Serni S, Carrieri G, Antonelli A, Li Marzi V. Balzarro M, et al. Among authors: mancini v. Ther Adv Urol. 2021 Nov 19;13:17562872211058246. doi: 10.1177/17562872211058246. eCollection 2021 Jan-Dec. Ther Adv Urol. 2021. PMID: 34819996 Free PMC article.
276 results